Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…tatic lung adenocarcinoma receiving carboplatin, pemetrexed and pembrolizumab presented with subacute bilateral lower limb oedema and erythem…
…fferent storage temperatures over a 28-day period.Methods Three bevacizumab 25 mg/mL vials (CT-P16) were stored punctured either light prot…
…r realistic, adult-representative breathing.Methods We assessed fluticasone propionate (FP, suspension) and ciclesonide (CIC, solution) using no VHC a…
…early half of alcohol-involved cases also involved THC. Routine THC testing in crash death investigations is essential for characte…
…ed in the dose-escalation phase, and TQB2618 (600 mg, Q3W) plus penpulimab (200 mg, Q3W) was selected as the RP2D. In the dose-expansion p…
…stem which included a warning for 5 days following a stat dose. Palonosetron can not be prescribed as stat standalone item. It can only be p…
…n period following the cessation of nebulised anti-PsA therapy. Dornase alfa was discontinued in 11 cases (14%); one restarted due to mucous…
…ffectiveness per intraoesophageal catheter; loop gain) modified AtoOxy effectiveness.Results AHI was lowered by −23.8 (−35.2, −10.6)% …
…ce and/or pharmacokinetic tolerance) in some patients receiving alfentanil.…
…Introduction Previous studies suggest that inequalities in statin prescribing exist for the primary and secondary prevention of c…
…from real-world clinical practice (RWE) remains limited.Methods Adalimumab vs Ixekizumab Real-world Effectiveness is a multicentre cohort …
…Background and Importance The introduction of the ustekinumab biosimilar (UB) offers a new opportunity for cost savings for h…